For: | Triantafillidis JK, Konstadoulakis MM, Papalois AE. Immunotherapy of gastric cancer: Present status and future perspectives. World J Gastroenterol 2024; 30(8): 779-793 [PMID: 38516237 DOI: 10.3748/wjg.v30.i8.779] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i8/779.htm |
Number | Citing Articles |
1 |
Dong Luo, Yunmei Liu, Zhengmao Lu, Lei Huang. Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01075-y
|
2 |
Vasile Bintintan, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Gabriel Samasca. Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update. Diagnostics 2024; 14(12): 1247 doi: 10.3390/diagnostics14121247
|
3 |
Chandana Yesudas, Yoga Soundarya Mohan, Jayaprakash Senthil, Ponmathi Panneerpandian, Krishnaveni Ganesan, Anisha Marina Mariyanayagam, Srutimanjari Parida, Illakkiam Devaraj, Kumaresan Ganesan. Identification of molecular therapeutic features of the homeopathy medicine Thuja by genome-wide expression profiling. Pharmacological Research - Modern Chinese Medicine 2025; 15: 100596 doi: 10.1016/j.prmcm.2025.100596
|
4 |
Yulai Yin, Xiaoyu Zhang. The burden and trends of gastric cancer from 1990 to 2021 in China and globally: a cross-sectional study. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1533544
|
5 |
Jane E. Rogers, Qiong Gan, Rebecca E. Waters, Ashley A. Horak, Jaffer A. Ajani. Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art. Expert Opinion on Biological Therapy 2024; 24(10): 1005 doi: 10.1080/14712598.2024.2401622
|
6 |
Yuxin Wang, Tong Xie, Shuai Xiang, Cheng Liu, Siyuan Cheng, Bohan Zhang, Yifan Zhang, Yang Feng, Yingxuan Wang, Donghe Yu, Hongchao Gao, Erke Gao, Lin Shen, Zhi Peng. Comparison of immune checkpoint inhibitors in combination with chemotherapy versus chemotherapy alone in the first-line treatment of advanced gastric cancer patients with low PD-L1 expression: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251336627
|
7 |
Yichao Wang, Hao Yuan, Yayun Tan, Li Wu, Xinchen Zhao, Zeyuan Yang, Shaoxing Dai, Naixue Yang. A novel Tc17 population recruited by tumor cells promotes tumor progression in gastric cancer. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1592328
|
8 |
Zijie Wei, Ziqian Kou, Yun Luo, Yu Cheng. DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer. Medicine 2025; 104(7): e41578 doi: 10.1097/MD.0000000000041578
|